Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer
NCT01013129 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 748
Last updated 2021-11-11
Summary
RATIONALE: Gathering information about genetic and environmental factors may help doctors learn more about a person's risk for developing prostate cancer.
PURPOSE: This research project is studying genes, environment, and prostate cancer risk in patients with or without prostate cancer.
Conditions
- Hereditary Prostate Cancer
- Prostate Cancer
Interventions
- GENETIC
-
DNA analysis
saliva samples will be collected from men (probands) who join the study.
- GENETIC
-
polymorphism analysis
we will genotype DNA samples (buccal) from all probands and conduct a traditional case-control analysis
- OTHER
-
laboratory biomarker analysis
10ml blood specimen will be obtained and processed (on probands locally-consented and/or those who have an appointment at the VA in Portland, Oregon) to allow for analyses of erythrocyte fatty acids and future nutrient and DNA analyses
- OTHER
-
medical chart review
PSA results, prostate biopsy pathology reports and clinician notes related to the biopsy are reviewed for final data analysis
- OTHER
-
questionnaire administration
probands are asked to complete questionnaires on 1) family history of cancer, 2) diet history over the past year, 3) employment environment and risk factors and/or 4) changes to diet, medications since enrollment in originating case control study
- PROCEDURE
-
evaluation of cancer risk factors
pathology reports will be reviewed for probands whose prostate biopsies reveal cancer; these factors will be evaluated for cancer risk factors
- PROCEDURE
-
study of high risk factors
prostate biopsy pathology reports will be reviewed for high risk factors
Sponsors & Collaborators
-
Portland VA Medical Center
lead FED
Principal Investigators
-
Jackilen Shannon, PhD · Portland VA Medical Center
Eligibility
- Min Age
- 21 Years
- Max Age
- 120 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-07-31
- Primary Completion
- 2012-12-31
- Completion
- 2012-12-31
Countries
- United States
Study Locations
More Related Trials
-
Streamlined Genetic Testing in Prostate Cancer
NCT04359758 ·Status: COMPLETED ·Phase: NA
-
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
NCT05295407 ·Status: RECRUITING
-
Precision-Based Genomics in Prostate Cancer
NCT04706663 ·Status: RECRUITING
-
Prostate Cancer Screening in Men With Germline BRCA2 Mutations
NCT02154672 ·Status: COMPLETED
-
Epidemiologic and Genetic Study on Familial Prostate Cancer
NCT01221168 ·Status: RECRUITING
-
Genetic Analysis of Prostate Cancer to Identify Predictive Markers of Disease Relapse or Metastatic Evolution
NCT03421015 ·Status: COMPLETED
-
Facilitating Participation in a Prostate Cancer Risk Assessment Program
NCT02126319 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Multimodal Strategy for Early Diagnosis of Men at High Genetic Risk of Prostate Cancer
NCT05333432 ·Status: WITHDRAWN ·Phase: NA
-
Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis
NCT01350180 ·Status: WITHDRAWN
-
The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment
NCT02543905 ·Status: RECRUITING
-
An Exploration of Genetic Testing for Prostate Cancer Susceptibility
NCT00997464 ·Status: UNKNOWN
-
The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer
NCT00261456 ·Status: ACTIVE_NOT_RECRUITING
-
Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer
NCT03789253 ·Status: RECRUITING
-
Familial Prostate Cancer
NCT00001377 ·Status: COMPLETED
-
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
NCT04472338 ·Status: RECRUITING
-
Markers for Early Detection of Prostate Cancer
NCT00340717 ·Status: COMPLETED
-
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
NCT02594202 ·Status: RECRUITING
-
The ProCaRis Study: Prostate Cancer Risk Assessment in General Practice
NCT01739062 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Enhanced Genetic Awareness and Genetic Evaluation for Men Through Technology, ENGAGEMENT Study
NCT04789018 ·Status: ACTIVE_NOT_RECRUITING
-
Optimizing Veteran-Centered Prostate Cancer Survivorship Care
NCT01900561 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of the PROGENSA(Registered Trademark) Prostate Cancer Gene 3 (PCA3) Assay in Men With a Previous Negative Biopsy Result
NCT01024959 ·Status: COMPLETED ·Phase: NA
-
Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male Participants
NCT00898274 ·Status: COMPLETED
-
Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer
NCT00967889 ·Status: UNKNOWN
-
Impact of Exercise on Prognostic Biomarkers Related to Prostate Cancer
NCT03397030 ·Status: COMPLETED ·Phase: NA
-
Metabolomic Study for Localized Prostate Cancer
NCT01968538 ·Status: UNKNOWN